Abstract:Mammalian cell expression systems are the most commonly used platforms for producing biotherapeutic proteins. However, development of recombinant mammalian cell lines is often hindered by the unstable and variable transgene expression associated with random integration. We have developed an efficient strategy for site-specific integration of genes of interest (GOIs). This method enables rapid and precise insertion of a gene expression cassette at defined loci in mammalian cells, resulting in homogeneous transgene expression. We identified the Hipp11 (H11) gene as a "safe harbor" locus for gene knock-in in CHO-S cells. Using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 mediated homologous recombination, we knocked in a DNA cassette (the landing pad) that includes a pair of PhiC31 bacteriophage attP sites and genes facilitating integrase-based GOI integration. A master cell line, with the landing pad inserted correctly in the H11 locus, was established. This master cell line was used for site-specific, irreversible recombination, catalyzed by PhiC31 integrase. Using this system, an integration efficiency of 97.7% was achieved with green fluorescent protein (GFP) after selection. The system was then further validated in HEK293T cells, using an analogous protocol to insert the GFP gene at the ROSA26 locus, resulting in 90.7% GFP-positive cells after selection. In comparison, random insertion yielded 0.68% and 1.32% GFP-positive cells in the CHO-S and HEK293T cells, respectively. Taken together, these findings demonstrated an accurate and effective protocol for generating recombinant cell lines to provide consistent protein production. Its likely broad applicability was illustrated here in two cell lines, CHO-S and HEK293T, using two different genomic loci as integration sites. Thus, the system is potentially valuable for biomanufacturing therapeutic proteins.

A Versatile Method for Inducible Protein Production in 293 Cells Using the PiggyBac Transposon System

Simple piggyBac transposon-based mammalian cell expression system for inducible protein production

A Transgenic Bm Cell Line of Piggybac Transposon-Derived Targeting Expression of Humanized Glycoproteins Through N-glycosylation.

A combination of targeted toxin technology and the piggyBac‐mediated gene transfer system enables efficient isolation of stable transfectants in nonhuman mammalian cells

[The Improvement and Application of Piggybac Transposon System in Mammals].

Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors

A system for site-specific integration of transgenes in mammalian cells

Transgene-free production of pluripotent stem cells using piggyBac transposons

EPISOMAL VECTORS FOR STABLE PRODUCTION OF RECOMBINANT PROTEINS AND ENGINEERED ANTIBODIES

Recombinant CHO Cell Pool Generation Using PiggyBac Transposon System

Generation of stable cell lines for the production of therapeutic proteins using the Piggy Bac transposon for transgene delivery

In Vitro Synthesis, Delivery, and Bioavailability of Exogenous mRNA in Gene Transfer Mediated by PiggyBac Transposition

Bacterial Artificial Chromosome-based Protein Expression Platform Using the Tol2 Transposon System

Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells

Recombinant Protein Production in Suspension Mammalian Cells Using the BacMam Baculovirus Expression System

An optimized polymeric delivery system for piggyBac transposition

A self-inducible heterologous protein expression system in Escherichia coli

A highly efficient transposon vector system for recombinant protein expression in CHO cells

Construction of Transgenic Macropodus opercularis by Transposon piggyBac

Transient Recombinant Protein Expression in Mammalian Cells

The transgenic animal platform for biopharmaceutical production